Pricing Log in Create free account
Saturday 17 October 2026 Export HSIC’s income statement to Excel — free account

Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Henry Schein, Inc. (HSIC) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Henry Schein, Inc. (HSIC) trades at a EV/EBITDA of 12.0×. Over the past ten years it has ranged from 7.7× (April 2020) to 19.7× (December 2018); the current reading is higher than 50% of that period. That is below the Medical Distribution industry median of 17.8× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.7× 3.62%
FY2024 11.3× (14.43%)
FY2023 13.2× 7.99%
FY2022 12.3× 12.60%
FY2021 10.9× (19.32%)
FY2020 13.5× 16.23%
FY2019 11.6× (16.35%)
FY2018 13.9× 16.97%
FY2017 11.9× 5.37%
FY2016 11.3× (5.88%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 11.7× 6.86%
Mar 2026 10.9× (6.86%)
Dec 2025 11.7× 12.67%
Sep 2025 10.4× (9.00%)
42 more quarters

Against its own ten years

Low 7.7× High 19.7×
Ten-year median 12.0×
Current reading's percentile 50

EV/EBITDA against peers

Company EV/EBITDA
HKPD Cellyan Biotechnology Co., Ltd compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
ACH Accendra Health, Inc. compare 8.1×
HSIC Henry Schein, Inc. 12.0×
MCK McKesson Corporation compare 17.8×
CAH Cardinal Health, Inc. compare 17.9×
COR Cencora, Inc. compare 18.2×
Medical Distribution industry median 17.8×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on HSIC